CARL logo

CARL Carlsmed, Inc.

NASDAQ · Medical - Healthcare Information Services · Healthcare

$17.37
-0.37 (-2.09%)

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and r…

Market Cap: $476.01Mwww.carlsmed.com

Price

No data yet.

Social Signal Score

47
5d
—
30d
43
3 mentions
—
60d
47
6 mentions
—
90d
52
7 mentions
—
news: 7

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$21+20.9%
Low $17Median $20High $26
Current Consensus

Revenue

$21.55M+397.09%
$4.34M$10.08M$15.81M$21.55M
Dec 2023Sep 2026

Analyst Estimates

FY2025
$-2.24
$-2.54–$-2.00
2 analysts
FY2026
$-1.54
$-1.59–$-1.48
2 analysts
FY2027
$-1.54
$-1.55–$-1.53
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Michael Cordonnier
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
127
Beta
1.97
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
6.33
www.carlsmed.com